 With modern analytic methods from blood based biomaterial there seems to be an opportunity to correlate blood based tumor assessments with actual characteristics of the tumor. These include expression analysis, tumor mutation analysis, tumor gene copy number abberations and others. One of the main aims of the PRAEGNANT study is therefore to establish an infrastructure for the comprehensive analysis of tumor and metastatic molecular characteristics of the patient and the tumor. 